FindTrial
Sign In

The effects of perineural or intravenous dexmedetomidine on transversus abdominis plane block

The effects of perineural or intravenous dexmedetomidine on transversus abdominis plane block

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045615
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-20
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynaecopathia

Interventions

control group:transversus abdominis plane
intravenous dexmedetomidine group:intravenous dexmedetomidine
perineural dexmedetomidine group:perineural dexmedetomidine

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, ASA class I-II; 2. Patients scheduled for elective gynecological endoscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Poorly controlled hypertension, diabetes, cardiac dysfunction (ejection fraction 150 µmol/L) 2. The puncture contraindication syndrome, those who are allergic to research drugs; 3. Use opioids before surgery; 4. Myopathy, morbid obesity (body mass index > 30); 5. History of chronic pain, drug or alcohol abuse history; 6. Cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
Duration of transverse abdominis plane block;—

Secondary

MeasureTime frame
Postoperative pain;Postoperative nausea and vomiting;Quality of postoperative recovery;—

Countries

China

Contacts

Public ContactLin Jingyan

North Sichuan Medical College

419931094@qq.com+86 15983771119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026